Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: @milestone
11
Aug 08, 2010 04:41AM
6
Aug 08, 2010 09:02AM
23
Aug 08, 2010 02:27PM

Aug 08, 2010 02:50PM
2
Aug 08, 2010 03:35PM
14
Aug 08, 2010 06:34PM
5
Aug 08, 2010 07:33PM
7
Aug 08, 2010 08:56PM
5
Aug 08, 2010 09:53PM
3
Aug 08, 2010 10:18PM
5
Aug 08, 2010 11:14PM
2
Aug 09, 2010 12:33AM
5
Aug 09, 2010 04:25AM
13
Aug 09, 2010 07:02AM
9
Aug 09, 2010 07:59AM

But many shareholders (at least here at Agora) want a change now because they want the shareprice to increase now because they want to sell then

But with a newly recertified '336 the price should increase anyway, no matter who is on the BoD. Simply changing one BoD member isn't going to speed up licensing, which will underpin any price increase.

I have a "target price" but if I see further potential when that price is reached, I may still hold at least some to benefit from any additional increases over and above that target.

.

.

.

Be well

Share
New Message
Please login to post a reply